Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 212 of 212 entries
View as:

Short Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)

Phase: N/A Priority: Normal
NCT ID: NCT03900858 Org: User:
Start: 12/01/18 End: 06/01/22 Due: 06/01/23

Application of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study

Phase: N/A Priority: Normal
NCT ID: NCT06679244 Org: User:
Start: 12/04/24 End: 06/30/29 Due: 06/30/30

Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02594293 Org: User:
Start: 10/31/15 End: 09/30/22 Due: 09/30/23

Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06329622 Org: User:
Start: 05/01/24 End: 06/30/26 Due: 06/30/27

The Study of Microglia/Macrophages Involved Dynamic Evolution of Glioma Microenvironment and the Function and Visualization of Targeted Molecules of Glioma

Phase: N/A Priority: Normal
NCT ID: NCT04781764 Org: User:
Start: 11/09/20 End: 12/31/22 Due: 12/31/23

Neurodevelopment of Infants Exposed to General Anesthesia: a Multi-center Investigation

Phase: N/A Priority: Normal
NCT ID: NCT03629093 Org: User:
Start: 01/01/21 End: 12/30/24 Due: 12/30/25

Study of 18F-0502B PET Imaging Targeting α-synuclein in the Diagnosis of α-synuclein-related Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05757804 Org: User:
Start: 03/17/23 End: 01/14/24 Due: 01/14/25

The National Registry Study for the Real-world Patients with Parkinsonian Disorders in China

Phase: N/A Priority: Normal
NCT ID: NCT03649503 Org: User:
Start: 10/01/18 End: 09/30/33 Due: 09/30/34

LED Therapy for Third Molar Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06640439 Org: User:
Start: 10/14/24 End: 04/14/25 Due: 04/14/26

Bilateral Single-Electrode VO Combined With STN-DBS for Treating Meige Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06912282 Org: User:
Start: 03/06/25 End: 01/01/27 Due: 01/01/28

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS

Phase: N/A Priority: Normal
NCT ID: NCT04717908 Org: User:
Start: 01/20/21 End: 06/22/24 Due: 06/22/25

Alterations of Gut Microbiome, Function, and Its Intervention After Defunctioning Ileostomy

Phase: N/A Priority: Normal
NCT ID: NCT05759741 Org: User:
Start: 01/17/23 End: 07/17/24 Due: 07/17/25